Charme Capital Partners Acquires Majority Stake in Tema Sinergie

Charme Capital Partners Acquires Majority Stake in Bianalisi

June 17, 2021

Healthcare Services

Charme Capital Partners (via its Charme IV fund) has agreed to acquire a majority stake in Italian diagnostics and outpatient services group Bianalisi. The investment will support Bianalisi's consolidation push across Italy, expansion of service capabilities (including preventive genetics and telemedicine) and continued partnership with founder Giuliano Caslini, who will remain Chairman and CEO.

Charme Capital Partners Acquires 56% Stake in Animalia

July 3, 2024

Veterinary

Charme Capital Partners (via its Charme IV fund) has agreed to take a 56% stake in Animalia through a capital increase, partnering with founders Antonino Santalucia and Giorgio Romani who will remain co-CEOs and minority shareholders. The investment will fund Animalia's consolidation and organic growth plan—including targeted add‑ons and expansion of clinic services—across its network of more than 75 clinics in Italy.

Charme Capital Partners Acquires Prism Healthcare

March 1, 2022

Medical Devices

Charme Capital Partners’ Charme IV fund has acquired Prism Healthcare, a UK-based manufacturer and provider of specialist patient handling and care equipment. Limerston Capital will remain invested alongside the management team; Charme’s investment will support Prism’s organic growth, international expansion and continued buy-and-build strategy.

Charme Capital Partners and Miura Capital Acquire INDIBA from Magnum

February 28, 2022

Medical Devices

Private equity firms Charme Capital Partners and Miura Capital have completed the acquisition of INDIBA, a Barcelona-based developer of 448 kHz radio-frequency medical devices for physiotherapy, aesthetics and veterinary markets, from Magnum. The deal positions INDIBA for a next phase of growth, with plans to expand market reach, product portfolio and operations under the new ownership.

IMA Acquires Majority Stake in ATOP from Charme Capital Partners

May 21, 2019

Manufacturing

IMA has agreed to acquire a 63% stake in ATOP from Charme Capital Partners (Charme III), taking its total ownership to 84% (having held 21% since 2017). The transaction values ATOP at an enterprise value of approximately €380 million (with an estimated cash disbursement by IMA of ~€230 million) and positions IMA to expand into the high-growth E‑Mobility market while founders and Chairman Amedeo Felisa reinvest for a 6% stake.

Innova Capital Acquires CheMeS

April 17, 2019

Packaging

Innova Capital has agreed to acquire CheMeS M. Szperliński Sp. z o.o., a Polish manufacturer of self-adhesive and heat-shrink labels, from Abris Capital Partners (binding contract signed 17 April 2019). The deal is part of Innova's strategy to consolidate the Central European label market and follows its March 2019 majority investment in Embe Press; the transaction is subject to regulatory approval.